禽流感概念涨1.21%，主力资金净流入这些股

Core Insights - The avian influenza concept sector saw an increase of 1.21%, ranking 10th among concept sectors, with 16 stocks rising, including Zhongsheng Pharmaceutical which hit the daily limit, and Hualan Vaccine, Kangyuan Pharmaceutical, and Yiling Pharmaceutical showing notable gains of 7.22%, 4.53%, and 3.14% respectively [1][2] Group 1: Stock Performance - Zhongsheng Pharmaceutical led the sector with a net inflow of 7.32 billion yuan, while Kangyuan Pharmaceutical, Yiling Pharmaceutical, and Hualan Vaccine also experienced significant net inflows of 3274.76 million yuan, 3130.43 million yuan, and 2904.55 million yuan respectively [2][3] - The top gainers in the avian influenza concept included Zhongsheng Pharmaceutical with a daily increase of 9.98%, followed by Hualan Vaccine at 7.22%, and Kangyuan Pharmaceutical at 4.53% [3][4] Group 2: Market Trends - The avian influenza concept sector attracted a net inflow of 6.66 billion yuan today, with 10 stocks receiving net inflows, and 6 stocks exceeding 10 million yuan in net inflow [2] - The net inflow ratios for leading stocks were 36.05% for Zhongsheng Pharmaceutical, 8.22% for Dongfang Bio, and 7.21% for Rhine Bio, indicating strong investor interest in these companies [3][4]